Exclusive: Qwant asks French watchdog to take interim action against Microsoft, sources say
BRUSSELS, June 3 (Reuters) - Qwant has asked France's antitrust regulator to take action against Microsoft (MSFT.O), opens new tab for allegedly driving down the quality of the French search engine's results via Microsoft's Bing platform, people with direct knowledge of the matter said.
Qwant, which has historically relied on Microsoft's Bing platform, wants the regulator to take interim action against the U.S. tech giant while investigating its complaint, the sources said.
The French regulator has sought feedback from other search engines and will likely decide by September whether to take interim action and also whether to open a formal investigation into Microsoft, one of the people said.
Competition enforcers only take interim action if there is evidence that a company abuses its market power and has caused serious and immediate harm to the complainant.
The French competition enforcer and Qwant declined to comment.
"This complaint lacks merit. We are fully cooperating with the Autorite's investigation," a Microsoft spokesperson said, referring to the French watchdog.
Smaller European search engines typically rely on their bigger rivals' back-end technology to deliver search and news results.
Microsoft is a major player in the search-engine syndication sector but its smaller rivals fear the company will discontinue the service to their detriment.
Companies risk fines of as much as 10% of their global annual turnover for breaching French antitrust rules.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
29 minutes ago
- The Guardian
Millions in west do not know they have aggressive fatty liver disease, study says
More than 15 million people in the US, UK, Germany and France do not know they have the most aggressive form of fatty liver disease, according to research. Metabolic dysfunction-associated steatotic liver disease (MASLD) – the formal name for non-alcoholic fatty liver disease – occurs in people who drink no or minimal amounts of alcohol whose liver contains more than 5% fat. Around two-thirds of patients with type 2 diabetes are thought to have the condition, which is also associated with obesity, heart and circulatory disease. Around 5% of adults globally have the most aggressive form of MASLD. Metabolic dysfunction-associated steatohepatitis (MASH) causes fibrosis (scarring) and can lead to cirrhosis and is linked to greater risk of cardiovascular disease, chronic kidney disease and liver cancer. But the vast majority of people do not know they have the condition. An international group of researchers examined prevalence and diagnosis of aggressive fatty liver disease in the US, UK, Germany and France. The researchers found that just under 3% of people in the UK, France and Germany, and 4% of those in the US have MASH, but diagnosis rates were below 18%. That means about 20 million people in the US, UK, Germany and France are living with MASH but only 2.5 million people have a diagnosis, leaving more than three-quarters – about 16.7 million people – unaware they have the condition. The report, published in the Lancet Regional Health Europe and presented at an the meeting of the global thinktank on steatotic liver disease in Barcelona, Spain on Thursday, calls for a doubling in diagnosis rates from 2022 levels. Traditionally, MASH was diagnosed through biopsy, but now non-invasive methods, such as blood tests, ultrasound and MRI scans can be used. As a result, everyone with type 2 diabetes; obesity combined with one or more other risk factors; and those with persistently high liver enzymes should be screened for MASH, the researchers conclude. Dr Jeffrey Lazarus, the lead author of the paper and a professor of global health in New York and Barcelona, said: 'Undiagnosed MASH costs economies billions of pounds in lost productivity and poor health. Unless diagnosis rates are doubled, alongside similar increases in treatment and care, direct health costs alone are predicted to triple over the next 20 years.' Responding to the findings, Emmanouil Tsochatzis, a professor of hepatology at UCL and a consultant hepatologist at the Royal Free hospital, said: 'More than 15 million people across the US and Europe have the deadliest form of fatty liver disease – and don't know it. Without faster diagnosis and access to treatment, the human and economic toll will skyrocket.' The research has also prompted renewed calls for weight loss jabs to be used to treat MASH. Dr Paul Brennan, a co-author of the Lancet paper and a hepatologist at NHS Tayside, said: 'GLP-1s (including Wegovy and Mounjaro) offer the potential to resynchronise our metabolism, by introducing feelings of satiety – fullness – and delaying the time the stomach takes to empty. These effects often result in reduced calorie intake, and improvements in how the liver handles nutrients as a result of weight loss, thus reducing scar tissue formation in the liver.' Michael Betel, the president of the Fatty Liver Alliance, said: 'Too many people living with type 2 diabetes or obesity are never tested for MASH until it's too late. We need a huge increase in liver health assessments in patients living with these diseases, alongside lifestyle changes and for some, when appropriate, weight loss drugs to reduce blood sugar and appetite. While weight loss drugs weren't created to treat liver disease, trials suggest they could benefit multiple metabolic-related conditions, and improve our liver health.' Separately a study published on Wednesday found that the diabetes drug dapagliflozin, which reduces blood sugar levels, can also reduce fat levels and fibrosis in the liver.
The Sun
30 minutes ago
- The Sun
The Body Shop is making a comeback – and launching 7 new products – here are our honest thoughts
THIS time last year, it looked like we might be losing The Body Shop for good. In February 2024, the high-street beauty retailer went into administration, prompting 75 store closures and nearly 800 job cuts in the UK. 8 A combination of dwindling Christmas sales, changes in beauty trends and rising inflation had led to The Body Shop's downfall - despite it being worth £207million in 2023. Once the pioneers in sustainable beauty - the brand was the first global beauty label to unite against animal testing - it looked like it might be closing its doors forever. But, thankfully, it's come back with a bang! In 2024, a deal was struck between The Body Shop and cosmetic retail tycoon Mike Jatania, who acquired the business with his consortium, Auréa. With ambitious plans to keep all 113 stores open, The Body Shop is up and running, and in the black again, cashing in a healthy £2m profit during its first three months with Auréa. The Body Shop's social media accounts are booming, its stores are getting busier, and it's just dropped two exciting limited-edition product ranges - the cosy, warming Tender Tonka, and the zingy, summery Refreshing Passionfruit. Here's everything you need to know. Tender Tonka Limited Edition Range BUY HERE You can't argue with an EDT that costs just £22 - especially when it's as gorgeous as this. This lightly spiced, cosy fragrance has a festive feel to it, despite being launched during one of the warmest springs on record. With notes of creamy vanilla orchid, aromatic incense and fresh cedar, it'll keep you warm on al fresco summer evenings. 8 The Body Shop Tender Tonka Fragrance Mist, £13 A lighter and more refreshing version of the EDT, this spritz is perfect for scent layering. The bottle produces a fine mist, which can be used on skin, clothes, and hair - or used as a base for your favourite perfume. The Body Shop Tender Tonka Body Cream, £20 Another great way to ensure your fragrance lasts longer is to layer it over a scented body cream, and here's the perfect formula. This thick, indulgent body cream has a butter-soft formula that creates a hydrating veil over the skin, thanks to softening shea butter, without feeling sticky. It leaves skin delicately scented and gloriously moisturised, without breaking the bank. New Beginning for The Body Shop Refreshing Passionfruit Limited Edition Range The Body Shop Refreshing Passionfruit Shower Gel, £8.50 Worlds apart from Tender Tonka's soft, cosy notes, Refreshing Passionfruit has a real zesty, fruity kick. This tangy but not overly sweet shower gel lathers into a sensual suds, and has delicious notes of vanilla, apple and peach. It's the perfect companion for an energising morning shower. The Body Shop Passionfruit Body Yogurt, £13 The Body Shop's Body Yogurt products are unlike anything you'll have tried before - think easy absorption, instant cooling and immediate hydration. The gel-like formula quickly sinks into skin, leaving it refreshed and beautifully scented. There's something very satisfying about this lightweight, juicy moisturiser - it needs to be tried to be believed! The Body Shop Refreshing Passionfruit Body Scrub, £19 If you're planning on fake tanning this summer, it's time to invest in a good body scrub. Using a scrub the night before you tan - whether you're doing it at home or going to a salon - helps buff away dead skin, bumps and imperfections, leaving you with a smoother finish. With kiwi seeds and passionfruit oil, plus tingling menthol, the formula leaves skin soft and glowing. Beach bags at the ready - this spritz is your perfect summer holiday companion. Perfect for tossing into a day bag, the quenching formula is packed with juicy passionfruit, soft vanilla and sugary peach. At just £13 a pop, this hydrating, water-based formula is a winner. What will you be adding to your basket this summer? How To Save Money On Beauty Buys IF your purse is feeling tighter than ever before and you're looking to save cash on your make-up routine, have you ever thought of trying out beauty dupes? Here are five of the best recommended beauty buys that are almost identical to the posh versions, but at a fraction of the price. FACE BASE If you can't afford Charlotte Tilbury 's £52 Magic Cream, why not try a dupe that costs just £5.49 from Superdrug? TONE IT UP If Drunk Elephant's £62 Protini Cream is out of your price range, you'll need to check out the new dupe in Home Bargains. TINTING IT With Fenty's game-changer skin tint costing £29, a popular supermarket's affordable alternative might just be the thing for you. GET COVERED At £29 for a Tarte concealer, the new Primark dupe is much more affordable at just £3.50. SPRAY YAY For those wanting to smell fresh without the price tag, Aldi's new Prada and Chloe perfume dupes cost a fraction of the price.
Reuters
36 minutes ago
- Reuters
Maserati ready to present new business plan very soon, brand boss says
MODENA, Italy, June 5 (Reuters) - Maserati plans to present a new business plan shortly, soon after parent company Stellantis' new CEO Antonio Filosa officially starts in his job later this month, the head of the struggling luxury carmaker said on Thursday. The loss-making Italian brand, the only one in the luxury segment for the world's fourth largest automaker, has no new model launches scheduled at the moment, with Stellantis reviewing Maserati's strategies after a previous business plan was put on hold last year. Maserati CEO Santo Ficili said the plan was being finalised and would not just include new products but also redesign relations with dealers and the assistance network. "We have clear ideas about what we want to do, we hope we can be ready very soon," Ficili said at the Motor Valley Fest in the Italian city of Modena, where Maserati is headquartered. "Let's wait for Antonio to take up his job," he added. Stellantis last week named its North American chief Filosa, an Italian national, as its new CEO. His appointment will be effective from June 23. "Antonio loves the (Maserati) brand, I am sure we'll do great things," Ficili said, adding Maserati will continue to design, engineer and manufacture all its models in Italy. Asked about market speculation that Stellantis could assess a sale of Maserati amid poor results and falling sales, Ficili reiterated the group had no plans at all to divest from it. Ficili, who is also the head of Stellantis premium brand Alfa Romeo, said a review of the Alfa plan was imminent too. The group has hired consultant McKinsey to advise on strategies for Maserati and Alfa Romeo as they face a hit from U.S. tariffs. Maserati makes around 30% of its sales in the U.S., while Alfa Romeo generates some 15%.
